Shelby Walker
Trading-Equity chez Becker Capital Management, Inc.
Fortune : - $ au 31/03/2024
Profil
Ms. Shelby J.
Walker is a Secretary, Senior Vice President & General Counsel at Korro Bio, Inc. and a Director at Becker Capital Management, Inc. Ms. Walker was previously employed as a General Counsel by Gingko Bioworks, a Chief IP Counsel, VP & Associate General Counsel by Dyax Corp., a Senior Vice President & Head-Intellectual Property by CRISPR Therapeutics AG, an IP Counsel by Novo Nordisk Pharma AG, and a Senior Patent Attorney by ZymoGenetics, Inc. She received her undergraduate degree from Worcester Polytechnic Institute, a graduate degree from the University of New Hampshire School of Law and a graduate degree from The Johns Hopkins University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 03/11/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Shelby Walker
| Sociétés | Poste | Début |
|---|---|---|
Becker Capital Management, Inc.
 Becker Capital Management, Inc. Investment ManagersFinance Becker Capital Management, Inc. (BCM) is an independent, SEC-registered investment advisor headquartered in Portland, Oregon and additional office in Seattle, Washington. The firm was founded by Patrick Becker, Sr. in 1976. BCM provides a range of investment management services for high-net-worth individuals, families, institutional investors and nonprofit organizations. | Trading-Equity | 01/01/1997 |
Anciens postes connus de Shelby Walker
| Sociétés | Poste | Fin |
|---|---|---|
| Gingko Bioworks | General Counsel | 01/03/2018 |
| DYAX CORP. | General Counsel | 01/06/2016 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Novo Nordisk Pharma AG
 Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - |
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | - |
Formation de Shelby Walker
| The Johns Hopkins University | Graduate Degree |
| Worcester Polytechnic Institute | Undergraduate Degree |
| University of New Hampshire School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Becker Capital Management, Inc.
Becker Capital Management, Inc. Investment ManagersFinance Becker Capital Management, Inc. (BCM) is an independent, SEC-registered investment advisor headquartered in Portland, Oregon and additional office in Seattle, Washington. The firm was founded by Patrick Becker, Sr. in 1976. BCM provides a range of investment management services for high-net-worth individuals, families, institutional investors and nonprofit organizations. | Finance |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Novo Nordisk Pharma AG
Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Health Technology |
| Gingko Bioworks |
